143 related articles for article (PubMed ID: 31482071)
1. Trends of Postoperative Radiotherapy for Completely Resected Non-small Cell Lung Cancer in China: A Hospital-Based Multicenter 10-Year (2005-2014) Retrospective Clinical Epidemiological Study.
Men Y; Wang L; Zhang Y; Gao S; Li J; Wu N; Yang B; Liu S; Ren J; Huang Y; Wang D; Liao X; Xing X; Du L; Yang L; Liu Y; Zhang Y; Wei D; Liu Y; Zhang K; Qiao Y; Shi J; Chen W; Dai M; Hui Z
Front Oncol; 2019; 9():786. PubMed ID: 31482071
[No Abstract] [Full Text] [Related]
2. Postoperative Radiotherapy for Resected Stage IIIA-N2 Non-small-cell Lung Cancer: A Population-Based Time-Trend Study.
Zeng WQ; Feng W; Xie L; Zhang CC; Yu W; Cai XW; Fu XL
Lung; 2019 Dec; 197(6):741-751. PubMed ID: 31705271
[TBL] [Abstract][Full Text] [Related]
3. Trends in the use of postoperative radiotherapy for resected non-small-cell lung cancer.
Bekelman JE; Rosenzweig KE; Bach PB; Schrag D
Int J Radiat Oncol Biol Phys; 2006 Oct; 66(2):492-9. PubMed ID: 16814952
[TBL] [Abstract][Full Text] [Related]
4. Outcome and prognostic factors of postoperative radiation therapy (PORT) after incomplete resection of non-small cell lung cancer (NSCLC).
Rieber J; Deeg A; Ullrich E; Foerster R; Bischof M; Warth A; Schnabel PA; Muley T; Kappes J; Heussel CP; Welzel T; Thomas M; Steins M; Dienemann H; Debus J; Hoffmann H; Rieken S
Lung Cancer; 2016 Jan; 91():41-7. PubMed ID: 26711933
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of Postoperative Radiotherapy Effect on Survival of Resected Stage III-N2 Non-small Cell Lung Cancer Patients.
Gao F; Li N; Xu Y; Yang G
Front Oncol; 2020; 10():1135. PubMed ID: 32850322
[No Abstract] [Full Text] [Related]
6. Association between clinicopathological factors and postoperative radiotherapy in patients with completely resected pathological N2 non-small cell lung cancer.
Xu Y; Li J; Wang J; Hu X; Ma H; Li P; Zheng X; Chen M
Oncol Lett; 2018 Feb; 15(2):2641-2650. PubMed ID: 29434986
[TBL] [Abstract][Full Text] [Related]
7. Association Between Radiation Dose and Outcomes With Postoperative Radiotherapy for N0-N1 Non-Small Cell Lung Cancer.
Wang EH; Corso CD; Park HS; Chen AB; Wilson LD; Kim AW; Decker RH; Yu JB
Am J Clin Oncol; 2018 Feb; 41(2):152-158. PubMed ID: 26523443
[TBL] [Abstract][Full Text] [Related]
8. The emerging outcome of postoperative radiotherapy for stage IIIA(N2) non-small cell lung cancer patients: based on the three-dimensional conformal radiotherapy technique and institutional standard clinical target volume.
Feng W; Zhang Q; Fu XL; Cai XW; Zhu ZF; Yang HJ; Xiang JQ; Zhang YW; Chen HQ
BMC Cancer; 2015 May; 15():348. PubMed ID: 25934006
[TBL] [Abstract][Full Text] [Related]
9. A narrative review of postoperative adjuvant radiotherapy for non-small cell lung cancer.
Olmetto E; Perna M; Cerbai C; Aquilano M; Banini M; Mariotti M; Livi L; Scotti V
Mediastinum; 2022; 6():4. PubMed ID: 35340837
[TBL] [Abstract][Full Text] [Related]
10. The lymph node status and histologic subtypes influenced the effect of postoperative radiotherapy on patients with N2 positive IIIA non-small cell lung cancer.
Yuan C; Tao X; Zheng D; Pan Y; Ye T; Hu H; Xiang J; Zhang Y; Chen H; Sun Y
J Surg Oncol; 2019 Mar; 119(3):379-387. PubMed ID: 30536966
[TBL] [Abstract][Full Text] [Related]
11. Early postoperative radiotherapy is associated with improved outcomes over late postoperative radiotherapy in the management of completely resected (R0) Stage IIIA-N2 non-small cell lung cancer.
Wang HH; Deng L; Wen QL; Zhang CZ; Zaorsky NG; Zhang BL; Chen J; Zeng XL; Cui YL; Shi YY; Hou HL; Wang W; Jiang B; Wang J; Pang QS; Zhao LJ; Yuan ZY; Wang P; Meng MB
Oncotarget; 2017 Sep; 8(38):62998-63013. PubMed ID: 28968966
[TBL] [Abstract][Full Text] [Related]
12. The role of postoperative radiotherapy for completely resected pIIIA-N2 non-small cell lung cancer patients with different clinicopathological features: a systemic review and meta-analysis.
Liu T; Mu Y; Dang J; Li G
J Cancer; 2019; 10(17):3941-3949. PubMed ID: 31417638
[No Abstract] [Full Text] [Related]
13. Propensity score-matching analysis of postoperative radiotherapy for stage IIIA-N2 non-small cell lung cancer using the Surveillance, Epidemiology, and End Results database.
Wei S; Xie M; Tian J; Song X; Wu B; Liu L
Radiat Oncol; 2017 Jun; 12(1):96. PubMed ID: 28610591
[TBL] [Abstract][Full Text] [Related]
14. Re-evaluation of the role of postoperative radiotherapy and the impact of radiation dose for non-small-cell lung cancer using the National Cancer Database.
Corso CD; Rutter CE; Wilson LD; Kim AW; Decker RH; Husain ZA
J Thorac Oncol; 2015 Jan; 10(1):148-55. PubMed ID: 25325781
[TBL] [Abstract][Full Text] [Related]
15. Postoperative radiotherapy for patients with completely resected pathological stage IIIA-N2 non-small cell lung cancer: focusing on an effect of the number of mediastinal lymph node stations involved.
Matsuguma H; Nakahara R; Ishikawa Y; Suzuki H; Inoue K; Katano S; Yokoi K
Interact Cardiovasc Thorac Surg; 2008 Aug; 7(4):573-7. PubMed ID: 18413349
[TBL] [Abstract][Full Text] [Related]
16. Patterns of Locoregional Relapses in Patients with Contemporarily Staged Stage III-N2 NSCLC Treated with Induction Chemotherapy and Resection: Implications for Postoperative Radiotherapy Target Volumes.
Billiet C; De Ruysscher D; Peeters S; Decaluwé H; Vansteenkiste J; Dooms C; Deroose CM; De Leyn P; Hendrikx M; Bulens P; Le Péchoux C; Mebis J
J Thorac Oncol; 2016 Sep; 11(9):1538-49. PubMed ID: 27374454
[TBL] [Abstract][Full Text] [Related]
17. Postoperative Radiation Therapy Is Associated With Improved Overall Survival in Incompletely Resected Stage II and III Non-Small-Cell Lung Cancer.
Wang EH; Corso CD; Rutter CE; Park HS; Chen AB; Kim AW; Wilson LD; Decker RH; Yu JB
J Clin Oncol; 2015 Sep; 33(25):2727-34. PubMed ID: 26101240
[TBL] [Abstract][Full Text] [Related]
18. Role of Postoperative Radiotherapy in Pathologic Stage IIIA (N2) Non-Small Cell Lung Cancer in a Prospective Nationwide Oncology Outcomes Database.
Herskovic A; Mauer E; Christos P; Nagar H
J Thorac Oncol; 2017 Feb; 12(2):302-313. PubMed ID: 27746190
[TBL] [Abstract][Full Text] [Related]
19. Role of adjuvant radiotherapy in completely resected non-small-cell lung cancer.
Péchoux CL; Mercier O; Belemsagha D; Bouaita R; Besse B; Fadel E
EJC Suppl; 2013 Sep; 11(2):123-30. PubMed ID: 26217121
[TBL] [Abstract][Full Text] [Related]
20. Predictors of relapse and evaluation of the role of postoperative radiation therapy in a modern series of patients with surgically resected stage III (N2) non-small cell lung cancer.
Breen WG; Merrell KW; Mansfield AS; Wigle DA; Garces YI; Park SS; Olivier KR; Hallemeier CL
Adv Radiat Oncol; 2017; 2(1):12-18. PubMed ID: 28740911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
